Non-invasive Parenteral Screening Market
Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA ... Read More
Tissue ablation is the process of destruction of diseased tissues to prevent disease proliferation. Tissue ablation uses radiofrequency electric current, microwaves, laser, and ultrasound to destroy diseased tissues, which is why it becomes a preferred choice of treatment owing to its minimally invasive nature.
This report contains market size and forecasts of Tissue Ablation Device in global, including the following market information:
Global Tissue Ablation Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Tissue Ablation Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Tissue Ablation Device companies in 2021 (%)
The global Tissue Ablation Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Radiofrequency Ablation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tissue Ablation Device include Boston Scientific, Medtronic, Johnson & Johnson, Abbott, Alcon, Biosense Webster, Alpinion Medical System, Smith & Nephew and BD and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tissue Ablation Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tissue Ablation Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Tissue Ablation Device Market Segment Percentages, by Type, 2021 (%)
Radiofrequency Ablation
Ultrasound Ablation
Laser-Based Ablation
Cryoablation Devices
Others
Global Tissue Ablation Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Tissue Ablation Device Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Tissue Ablation Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Tissue Ablation Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tissue Ablation Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Tissue Ablation Device revenues share in global market, 2021 (%)
Key companies Tissue Ablation Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Tissue Ablation Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boston Scientific
Medtronic
Johnson & Johnson
Abbott
Alcon
Biosense Webster
Alpinion Medical System
Smith & Nephew
BD
Stryker
Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA ... Read More
Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA ... Read More
Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth ... Read More
Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth ... Read More